Cleared Traditional

K212419 - Magnifico Open, Magnifico MSK

K212419 is an FDA 510(k) clearance for Magnifico Open, manufactured by Esaote, S.P.A.. The device is a Class 2 Radiology device with product code LNH cleared through the Traditional 510(k) pathway after a 184-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
184d
Days
Class 2
Risk

K212419 is an FDA 510(k) clearance for the Magnifico Open, Magnifico MSK. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Esaote, S.P.A. (Genoa, IT). The FDA issued a Cleared decision on February 4, 2022 after a review of 184 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Esaote, S.P.A. devices

FDA 510(k) Submission Details - K212419

510(k) Number K212419 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2021
Decision Date February 04, 2022
Days to Decision 184 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 107d · This submission: 184d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNH Device Classification - Class 2, Special Controls

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 961
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K212419.
MAGNETOM Vida with syngo MR XA50A
K213693 · Siemens Medical Solutions USA, Inc. · Feb 2022
SIGNA Artist Evo
K213603 · Ge Healthcare (Tianjin) Company Limited · Feb 2022
smart-sync
K212271 · Northh Medical GmbH · Feb 2022
SIGNA Hero
K213668 · Ge Healthcare (Ge Medical Systems, LLC) · Jan 2022
SIGNA Prime
K211980 · Ge Healthcare (Tianjin) Company Limited · Jan 2022
Vantage Fortian 1.5T, MRT-1550, V8.0 with AiCE Reconstruction Processing Unit for MR
K213305 · Canon Medical Systems Corporation · Dec 2021